Cite
Predictive Modeling of Alzheimer's and Parkinson's Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal Fluid.
MLA
Hwangbo, Nathan, et al. “Predictive Modeling of Alzheimer’s and Parkinson’s Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal Fluid.” Metabolites (2218-1989), vol. 12, no. 4, Apr. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.3390/metabo12040277.
APA
Hwangbo, N., Zhang, X., Raftery, D., Gu, H., Hu, S.-C., Montine, T. J., Quinn, J. F., Chung, K. A., Hiller, A. L., Wang, D., Fei, Q., Bettcher, L., Zabetian, C. P., Peskind, E. R., Li, G., Promislow, D. E. L., Davis, M. Y., & Franks, A. (2022). Predictive Modeling of Alzheimer’s and Parkinson’s Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal Fluid. Metabolites (2218-1989), 12(4), N.PAG. https://doi.org/10.3390/metabo12040277
Chicago
Hwangbo, Nathan, Xinyu Zhang, Daniel Raftery, Haiwei Gu, Shu-Ching Hu, Thomas J. Montine, Joseph F. Quinn, et al. 2022. “Predictive Modeling of Alzheimer’s and Parkinson’s Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal Fluid.” Metabolites (2218-1989) 12 (4): N.PAG. doi:10.3390/metabo12040277.